Long Term Outcomes in Evidence Based TCM Obesity Interventions Trial Data

Analysis of 18 RCTs shows evidence-based TCM obesity interventions sustain 5.2% weight loss at 12 months—outperforming conventional approaches on adherence and metabolic markers.

2026-03-23

Chinese Medicine Obesity Research Identifies Key Biomarkers for Treatment Response

New clinical research identifies 3 predictive biomarkers for TCM obesity treatment response — backed by multi-center data and real-world outcomes.

2026-03-23

Acupuncture Weight Loss Studies Reveal Neuroendocrine Modulation Pathways

Evidence-based analysis of acupuncture's role in weight loss via neuroendocrine pathways—backed by RCTs, fMRI, and biomarker data. Practical insights for clinicians and patients.

2026-03-23

Evidence Based TCM Herbal Therapies for Abdominal Obesity in Recent Studies

Clinically reviewed analysis of recent RCTs on TCM herbal formulas for abdominal obesity—featuring VFA data, biomarker changes, and safety metrics.

2026-03-23

Integrative TCM Weight Loss Strategies Backed by High Quality Clinical Evidence

Evidence-based analysis of integrative TCM weight loss strategies, backed by RCTs, biomarker data, and real-world clinical outcomes — practical, safe, and sustainable.

2026-03-23

Randomized Controlled Trials Validate Acupuncture Weight Loss Protocol Efficacy

RCT data confirms acupuncture weight loss protocols yield 3.2 kg avg loss in 8–12 weeks—superior to sham & lifestyle controls. Evidence, tables & mechanism explained.

2026-03-23

Role of Spleen Qi Regulation in Chinese Medicine Obesity Research Findings

Evidence-based analysis of Spleen Qi's role in obesity—backed by RCT data, fMRI insights, and clinical outcomes across 2,941 patients.

2026-03-23

Acupuncture Weight Loss Studies Support Neuroendocrine Adaptation in Energy Homeostasis

Evidence-based analysis of acupuncture's role in weight regulation via neuroendocrine pathways—backed by RCT data, biomarker trends, and autonomic metrics.

2026-03-20

Evidence Based TCM Protocols Reduce Cardiovascular Risk Factors in Obese Cohorts

Clinical data shows evidence based TCM protocols significantly reduce BP, LDL-C, and insulin resistance in obese adults—backed by RCTs and meta-analyses.

2026-03-20

Chinese Medicine Obesity Research Confirms Anti Fibrotic Effects in Hepatic Steatosis

New clinical evidence confirms Chinese medicine obesity interventions deliver measurable anti-fibrotic effects in hepatic steatosis — with 43.7% fibrosis regression at 24 weeks.

2026-03-20